Full View

Salt‐inducible kinase 2‐triggered release of its inhibitor from hydrogel to suppress ovarian cancer metastasis

Y Hua, H Yin, X Liu, J Xie, W Zhan, G Liang… - Advanced …, 2022 - Wiley Online Library
Abstract Salt‐inducible kinase 2 (SIK2) is a promising target for ovarian cancer therapy due
to its critical role in tumorigenesis and progression. Currently available SIK2 inhibitors have …
被引用次数：15 相关文章

Salt-Inducible Kinase 2-Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis.

Y Hua, H Yin, X Liu, J Xie, W Zhan… - Advanced Science …, 2022 - europepmc.org
Abstract Salt‐inducible kinase 2 (SIK2) is a promising target for ovarian cancer therapy due
to its critical role in tumorigenesis and progression. Currently available SIK2 inhibitors have …
[HTML] nih.gov

[HTML][HTML] Salt‐Inducible Kinase 2‐Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis

Y Hua, H Yin, X Liu, J Xie, W Zhan, G Liang… - Advanced …, 2022 - ncbi.nlm.nih.gov
Abstract Salt‐inducible kinase 2 (SIK2) is a promising target for ovarian cancer therapy due
to its critical role in tumorigenesis and progression. Currently available SIK2 inhibitors have …

Salt-Inducible Kinase 2-Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis

Y Hua, H Yin, X Liu, J Xie, W Zhan… - Advanced science …, 2022 - pubmed.ncbi.nlm.nih.gov
Salt-inducible kinase 2 (SIK2) is a promising target for ovarian cancer therapy due to its
critical role in tumorigenesis and progression. Currently available SIK2 inhibitors have …

Salt‐Inducible Kinase 2‐Triggered Release of Its Inhibitor from Hydrogel to Suppress Ovarian Cancer Metastasis

H Yue, Y Han, X Liu, J Xie, W Zhan, G Liang… - Advanced …, 2022 - search.proquest.com
Abstract Salt‐inducible kinase 2 (SIK2) is a promising target for ovarian cancer therapy due
to its critical role in tumorigenesis and progression. Currently available SIK2 inhibitors have …